Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-24 @ 2:51 PM
NCT ID:
NCT00777959
Eligibility Criteria:
Inclusion Criteria:
* Confirmed adenocarcinomas of the prostate.
* Evidence of metastatic disease
* Evidence of disease progression including one of the following: increasing levels of PSA, progressive lymph node disease, or worsening bone scan
* PSA level is greater or equal to 7 ng/ml.
* ECOG performance status less than or equal to 1
Exclusion Criteria :
* Previously received bicalutamide, flutamide, or nilutamide within the past 12 months (except for a period of use less than 30 days long).
* Prior chemotherapy for prostate cancer
* Prior rapamycin or rapamycin analogs, including ridaforolimus, everolimus, or temsirolimus.
* Patient is receiving an opioid or narcotic analgesic for pain due to prostate cancer
* Patient has pain related to prostate cancer that warrants the initiation of chemotherapy
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00777959
Study Brief:
Protocol Section:
NCT00777959